Roles of ubiquitin and SUMO during chromosomal DNA replication.
泛素和 SUMO 在染色体 DNA 复制过程中的作用。
基本信息
- 批准号:MR/K007106/1
- 负责人:
- 金额:$ 141.38万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2013
- 资助国家:英国
- 起止时间:2013 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cell division is the basis for the propagation of life. This involves the precise duplication of genetic information, which is called DNA replication. This process must be, and is, precisely regulated. Any mistakes that are not subsequently repaired can change the way the cell behaves and result in conditions such as genetic diseases, cancer and ageing. It is fascinating that in most cases cells can achieve this task of duplicating the whole genome precisely once and without mistakes. Genome duplication is also essential for fast dividing cancer cells. It is why many anti-cancer therapies target DNA replication, but these are so far not specific for cancer cells and have significant side-effects. It is therefore crucial that we fully understand this fundamental process so that we can develop better and more specific anti-cancer strategies. Cells have developed many ways of dealing with damaged DNA to maintain an intact genome. Last few years brought to light the importance of small-protein modifiers called ubiquitin and SUMO in regulating key DNA repair proteins. There is strong evidence to suggest that these modifications are also important during the replication of undamaged DNA. However little is known about the proteins they are targeting. The aim of my project is to investigate the role of ubiquitin and SUMO during replication of undamaged DNA.Two biological systems will be used to fulfill this project. The cell-free system using extracts from the eggs of the African clawed frog (Xenopus laevis) contains pre-formed complexes of most proteins required for cell cycle progression and so can support a complete round of DNA replication in a test tube. As many aspects of this process are highly similar in all eukaryotic organisms studied, the mechanisms identified in simpler egg extract model system are most often true also in human cells. Once novel modifications have been identified and basic mechanistic studies have been performed in Xenopus egg extract I would like to investigate whether analogous mechanism function also in human cells.In particular, I am interested in investigating the role of ubiquitin during the termination stage of DNA replication, as suggested by my preliminary data. Replication termination occurs when two DNA replication forks coming from the opposite sites of the chromosome fuse together. The efficient and faultless resolution of these structures is crucial for maintaining the genome integrity. There are thousands of replication forks in human cell which have to be resolved during each termination phase - it is crucial therefore that we create tools to study this process and determine its input towards tumorgenesis. However, this stage of DNA replication is also very poorly understood and therefore a very exciting research area. I will study the mechanism by which ubiquitylation regulates this process and the consequences of its disruption. In an analogous way, I will examine the effects of blocking sumoylation on different aspects of DNA replication.I would also like to take advantage of the simplicity of biochemical analysis of DNA replication in Xenopus system and perform a systematic analysis of proteins associating with replicating DNA and modified during DNA replication. I will then choose the most interesting ones and characterize the type and site of these modifications. My final aim is to determine the function of the identified modifications and their importance in process of DNA replication and cancer development.Defining the role of ubiquitin and SUMO modifications during DNA replication will widen our understanding of this process. Both DNA replication and the ubiquitin system are targeted by many current anti-cancer chemotherapies. Unveiling new crosstalk pathways between these two may therefore suggest novel targets or combinations of chemotherapeutic agents as it may reveal new ways of creating DNA damage specifically lethal to cancer cells.
细胞分裂是生命繁衍的基础。这涉及遗传信息的精确复制,称为DNA复制。这个过程必须并且确实受到精确监管。任何随后未修复的错误都可能改变细胞的行为方式并导致遗传疾病、癌症和衰老等疾病。令人着迷的是,在大多数情况下,细胞可以完成一次精确复制整个基因组的任务,而且不会出现错误。基因组复制对于快速分裂的癌细胞也至关重要。这就是为什么许多抗癌疗法都以 DNA 复制为目标,但迄今为止这些疗法都不是针对癌细胞的,并且具有显着的副作用。因此,我们充分了解这一基本过程至关重要,这样我们才能制定更好、更具体的抗癌策略。细胞已经发展出许多方法来处理受损的 DNA,以维持完整的基因组。过去几年,人们认识到泛素和 SUMO 小蛋白修饰剂在调节关键 DNA 修复蛋白方面的重要性。有强有力的证据表明,这些修饰在未受损 DNA 的复制过程中也很重要。然而,人们对它们所针对的蛋白质知之甚少。我的项目的目的是研究泛素和 SUMO 在未受损 DNA 复制过程中的作用。将使用两个生物系统来完成该项目。使用非洲爪蛙 (Xenopus laevis) 卵提取物的无细胞系统含有细胞周期进展所需的大多数蛋白质的预形成复合物,因此可以支持试管中完整一轮的 DNA 复制。由于该过程的许多方面在所有研究的真核生物中都高度相似,因此在更简单的鸡蛋提取物模型系统中确定的机制在人类细胞中也通常是正确的。一旦确定了新的修饰并在非洲爪蟾卵提取物中进行了基本机制研究,我想研究类似的机制是否也在人类细胞中发挥作用。特别是,我对研究泛素在 DNA 复制终止阶段的作用感兴趣,正如我的初步数据所示。当来自染色体相对位点的两个 DNA 复制叉融合在一起时,就会发生复制终止。这些结构的高效且完美的解析对于维持基因组完整性至关重要。人类细胞中有数千个复制叉,必须在每个终止阶段得到解决 - 因此,我们创建工具来研究这一过程并确定其对肿瘤发生的输入至关重要。然而,人们对 DNA 复制的这一阶段知之甚少,因此是一个非常令人兴奋的研究领域。我将研究泛素化调节这一过程的机制及其破坏的后果。以类似的方式,我将研究阻断苏酰化对 DNA 复制不同方面的影响。我还想利用非洲爪蟾系统中 DNA 复制生化分析的简单性,对与 DNA 复制相关的蛋白质进行系统分析并在 DNA 复制过程中进行修饰。然后我将选择最有趣的,并描述这些修改的类型和地点。我的最终目标是确定已识别修饰的功能及其在 DNA 复制和癌症发展过程中的重要性。定义泛素和 SUMO 修饰在 DNA 复制过程中的作用将拓宽我们对这一过程的理解。 DNA 复制和泛素系统都是当前许多抗癌化疗的目标。因此,揭示这两者之间新的串扰途径可能会提出新的靶点或化疗药物的组合,因为它可能揭示产生对癌细胞特别致命的DNA损伤的新方法。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanisms of eukaryotic replisome disassembly.
真核复制体拆卸的机制。
- DOI:http://dx.10.1042/bst20190363
- 发表时间:2020
- 期刊:
- 影响因子:3.9
- 作者:Moreno SP
- 通讯作者:Moreno SP
Two paths to let the replisome go
释放复制体的两种途径
- DOI:http://dx.10.1038/cdd.2017.75
- 发表时间:2017
- 期刊:
- 影响因子:12.4
- 作者:D'Angiolella V
- 通讯作者:D'Angiolella V
The Initiation of DNA Replication in Eukaryotes
真核生物中 DNA 复制的起始
- DOI:http://dx.10.1007/978-3-319-24696-3_17
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:De Piccoli G
- 通讯作者:De Piccoli G
Regulation of Unperturbed DNA Replication by Ubiquitylation.
通过泛素化调节不受干扰的 DNA 复制。
- DOI:http://dx.10.3390/genes6030451
- 发表时间:2015
- 期刊:
- 影响因子:3.5
- 作者:Moreno SP
- 通讯作者:Moreno SP
Termination of Eukaryotic Replication Forks.
真核复制叉的终止。
- DOI:http://dx.10.1007/978-981-10-6955-0_8
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Gambus A
- 通讯作者:Gambus A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Agnieszka Gambus其他文献
Mechanisms of eukaryotic replisome disassembly
真核复制体拆卸机制
- DOI:
10.1042/bst20190363 - 发表时间:
2020-06-03 - 期刊:
- 影响因子:3.9
- 作者:
S. Moreno;Agnieszka Gambus - 通讯作者:
Agnieszka Gambus
Mitotic replisome disassembly depends on TRAIP ubiquitin ligase activity
有丝分裂复制体分解取决于 TRAIP 泛素连接酶活性
- DOI:
10.26508/lsa.201900390 - 发表时间:
2019-04-01 - 期刊:
- 影响因子:4.4
- 作者:
Sara Priego Moreno;Rebecca M Jones;Divyasree Poovathumkadavil;Shaun Scaramuzza;Agnieszka Gambus - 通讯作者:
Agnieszka Gambus
MYBL2 regulates ATM to control replication initiation and prevent replication stress in pluripotent stem cells
MYBL2 调节 ATM 以控制多能干细胞的复制起始并防止复制应激
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Daniel R. Blakemore;Nuria Vilaplana;Ruba Almaghrabi;Elena González;Miriam Moya;C. Ward;G. Murphy;Agnieszka Gambus;E. Petermann;G. Stewart;P. García - 通讯作者:
P. García
The p97 segregase cofactor Ubxn7 facilitates replisome disassembly during S-phase
p97 分离酶辅助因子 Ubxn7 促进 S 期复制体分解
- DOI:
10.1016/j.jbc.2022.102234 - 发表时间:
2022-07-01 - 期刊:
- 影响因子:0
- 作者:
Zeynep Tarcan;Divyasree Poovathumkadavil;Aggeliki Skagia;Agnieszka Gambus - 通讯作者:
Agnieszka Gambus
Ubiquitin ligase TRAIP plays an essential role during the S-phase of unperturbed cell cycle in the resolution of DNA replication – transcription conflicts
泛素连接酶 TRAIP 在未受干扰的细胞周期 S 期解决 DNA 复制 - 转录冲突方面发挥着重要作用
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Shaun Scaramuzza;Martina Mustè Sadurnì;Divyasree Poovathumkadavil;Toyoaki Natsume;Patricia Rojas;Masato T. Kanemaki;Marco Saponaro;Agnieszka Gambus - 通讯作者:
Agnieszka Gambus
Agnieszka Gambus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Agnieszka Gambus', 18)}}的其他基金
The role of DONSON during DNA replication initiation
DONSON 在 DNA 复制起始过程中的作用
- 批准号:
BB/Y002458/1 - 财政年份:2024
- 资助金额:
$ 141.38万 - 项目类别:
Research Grant
Cryo-EM studies of a metazoan replisome captured ex vivo during elongation and termination
在延伸和终止过程中离体捕获的后生动物复制体的冷冻电镜研究
- 批准号:
BB/Y006232/1 - 财政年份:2024
- 资助金额:
$ 141.38万 - 项目类别:
Research Grant
TRAIP ubiquitin ligase driving replisome disassembly
TRAIP 泛素连接酶驱动复制体拆卸
- 批准号:
BB/T001860/1 - 财政年份:2019
- 资助金额:
$ 141.38万 - 项目类别:
Research Grant
相似国自然基金
类泛素蛋白SUMO2维持GPX4稳态抵御铁死亡进而介导食管癌放疗抵抗的机制与增敏放疗药物筛选研究
- 批准号:82360582
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
类泛素蛋白SUMO2抑制细胞有丝分裂灾难导致胰腺癌化疗耐药及其靶向创新分子药物筛选的研究
- 批准号:82372769
- 批准年份:2023
- 资助金额:62 万元
- 项目类别:面上项目
供肝SUMO4 A163G突变调控PXR类泛素化修饰对肝移植术后他克莫司代谢的影响和机制研究
- 批准号:82300748
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SUMO2通过类泛素化修饰IRF3导致肝癌射频消融残癌免疫抑制的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SUMO靶向的E3泛素连接酶RNF4在复制叉翻转与基因组稳定性维持中的功能与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of Sumo in piRNA-mediated germline heterochromatin maintenance in C.elegans
研究 Sumo 在 piRNA 介导的线虫种系异染色质维持中的作用
- 批准号:
10750099 - 财政年份:2023
- 资助金额:
$ 141.38万 - 项目类别:
The role of small ubiquitin-like modifier (SUMO) in DNA end resection
小泛素样修饰剂 (SUMO) 在 DNA 末端切除中的作用
- 批准号:
RGPIN-2017-05752 - 财政年份:2022
- 资助金额:
$ 141.38万 - 项目类别:
Discovery Grants Program - Individual
Genetic requirements for executing SUMO stress signals and achieving stress tolerance
执行 SUMO 应激信号和实现应激耐受性的遗传要求
- 批准号:
10514836 - 财政年份:2022
- 资助金额:
$ 141.38万 - 项目类别:
Rhes-SUMO Pathway in Huntington disease
亨廷顿病中的 Rhes-SUMO 通路
- 批准号:
10707942 - 财政年份:2022
- 资助金额:
$ 141.38万 - 项目类别:
The role of small ubiquitin-like modifier (SUMO) in DNA end resection
小泛素样修饰剂 (SUMO) 在 DNA 末端切除中的作用
- 批准号:
RGPIN-2017-05752 - 财政年份:2022
- 资助金额:
$ 141.38万 - 项目类别:
Discovery Grants Program - Individual